Jeffrey S. Hackman's Insider Trades & SAST Disclosures

Jeffrey S. Hackman's most recent trade in Fennec Pharmaceuticals Inc was a trade of 13,965 Common Shares done at an average price of $7.0 . Disclosure was reported to the exchange on May 16, 2025.

Share

Note

This is a custom search result for pattern Jeffrey S. Hackman.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Fennec Pharmaceuticals Inc	Jeffrey S. Hackman	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 6.99 per share.	16 May 2025	13,965	15,000 (0%)	0%	7.0	97,615	Common Shares
Fennec Pharmaceuticals Inc	Jeffrey S. Hackman	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 6.75 per share.	16 May 2025	1,035	1,035 (0%)	0%	6.7	6,986	Common Shares
Fennec Pharmaceuticals Inc	Jeffrey S. Hackman	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Mar 2025	75,000	475,000	-		-	Restricted Share Unit
Fennec Pharmaceuticals Inc	Jeffrey S. Hackman	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Mar 2025	50,000	525,000	-		-	Stock Options
Fennec Pharmaceuticals Inc	Jeffrey S. Hackman	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Aug 2024	400,000	400,000	-		-	Stock Options
Comera Life Sciences Holdi... 52 week low	Jeffrey S. Hackman	Director, See Remarks.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Feb 2023	100,000	100,000	-		-	Stock Option (Right to Purchase)
Comera Life Sciences Holdi... 52 week low	Jeffrey S. Hackman	Director, See Remarks	Purchase of securities on an exchange or from another person at price $ 2.06 per share.	09 Sep 2022	47,600	47,600	-	2.1	98,056	Common Stock
Comera Life Sciences Holdi... 52 week low	Jeffrey S. Hackman	Director, See Remarks.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Aug 2022	300,000	300,000	-		-	Stock Option (Right to Purchase)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades